Clinical trials: Mercury Poisoning
Ischemic Heart Disease, Coronary Artery Disease
Heavy Metals, Angiogenesis Factors and Osteopontin in Coronary Artery Disease (CAD)
The present study aims is to investigate: 1. whether patients suffering from acute resp. chronic ischemic heart disease show higher levels for cadmium (Cd), lead (Pb) and mercury (Hg) than local and international reference levels…
- Conditions
- Ischemic Heart Disease, Coronary Artery Disease, Heavy Metal Toxicity
- Trial name
- NCT02159235
- Where
- Austria
- Volunteers
- 200 people
- Sponsor
- Medical University of Vienna
Mercury Poisoning, Lead Poisoning
Environmental Contaminants and Infant Development
This study is designed to examine the effects of prenatal exposure to environmental contaminants on cognitive and behavioral development and physical growth in two groups of Inuit infants-one in Northern Quebec; the other in…
- Trial name
- NCT00013858
- Where
- Canada
- Volunteers
- 280 people, healthy volunteers welcome
- Sponsor
- National Institute of Environmental Health Sciences (NIEHS)
Mercury Poisoning
NBMI Treatment in Patients With Mercury Toxicity
NBMI (N1, N3-Bis-(2-Mercaptoethyl) Isophthalamide) is a new metal chelator drug proposed as an alternative to the current chelators, and it is widely different; compared to the current chelators, consisting of two cysteamine…
- Trial name
- NBMI-Hg-COL (NCT04183595)
- Testing
- (N1, N3-bis(2- mercaptoethyl)isophthalamide), Excipients microcrystalline cellulose, silica and magnesium stearate
- Where
- Colombia
- Volunteers
- 116 people, healthy volunteers welcome
- Sponsor
- EmeraMed
Mercury Poisoning
Pilot Proof of Concept Study of NBMI Treatment of Mercury Intoxication
A randomized, placebo controlled, double blind proof of concept study of NBMI in treatment of mercury intoxication.
- Trial name
- NBMI (NCT02486289)
- Testing
- Emeramide
- Where
- Ecuador
- Volunteers
- 36 people
- Sponsor
- EmeraMed